NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – GENERAL ORGANIZATION AND BUSINESS
Genufood
Energy Enzymes Corp., USA (the “Company” or “GEEC”) was incorporated under the laws of the State of Nevada on
June 21, 2010. On February 13, 2012, GEEC incorporated a wholly-owned subsidiary company, Genufood Enzymes (S) Pte Ltd (“GESPL”)
in Singapore.
The Company
is currently a shell company.
Since its
inception, the Company has always been in the development stage and never generated significant revenues. At this time, the Company does
not have any specific plan to commence any particular new business. The Company’s focus will be to consider either or both of a
possible business combination, which may include but not be limited to a reverse merger, with another operating business, or commencing
a business of its own.
The Company
made two investments in Hukui Biotechnology Corporation (“Hukui”) by purchasing 80,000 shares of Hukui’s Series C Preferred
Stock for $800,000 on December 15, 2020; and purchasing 60,000 shares of Hukui’s Series C Preferred Stock for $600,000 on June 25,
2021. The Company, an individual and resident of the Republic of China (the “Purchaser”), and Hukui, entered into a Stock
Purchase Agreement dated as of November 17, 2021, pursuant to which the Company agreed to sell these 140,000 shares of Hukui’s Series
C Preferred Stock (the “Hukui Shares”) to the Purchaser for $350,000 in cash, or $2.50 per share. The sale of the Hukui Shares
closed on November 19, 2021.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation
The Company’s condensed consolidated financial
statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).
The accompanying condensed consolidated financial statements reflect all adjustments, consisting of only normal recurring items, which,
in the opinion of management, are necessary for a fair statement of the results of operations for the periods shown and are not necessarily
indicative of the results to be expected for the full year ending September 30, 2022. These condensed consolidated financial statements
should be read in conjunction with the condensed consolidated financial statements and related notes included in the Company’s Annual
Report on Form 10-K for the year ended September 30, 2021.
Principle of Consolidation
The condensed consolidated financial statements
include the accounts of GEEC and its wholly-owned subsidiary GESPL. All significant inter-company accounts and transactions have been
eliminated in consolidation. The wholly-owned subsidiary of the Company did not have business activities during the nine months ended
June 30, 2022 and 2021.
Use of Estimates
The preparation of the consolidated financial
statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported
amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. For the nine months ended
June 30, 2022 and 2021, no significant estimates and assumptions have been made in the consolidated financial statements.
Concentrations of Credit Risk
Financial instruments that potentially subject
the Company to significant concentrations of credit risk consisted primarily of cash, to the extent balances exceeded limits that were
insured by the Federal Deposit Insurance Corporation. The Company does not require collateral and maintains reserves for potential credit
losses. Such losses have historically been immaterial and have been within management’s expectations.
Cash and Cash Equivalents
The Company considers
all highly liquid instruments with original maturities of three months or less when acquired to be cash equivalents. As of June 30, 2022
and September 30, 2021, the Company did not have cash equivalents. The Company’s cash was denominated in United States Dollars (“USD”)
or New Taiwan Dollars (“TWD”) and was placed with banks in the United States of America and Taiwan.
Fair Value of Financial Instruments
The Company follows the guidance of the ASC Topic
820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities
that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring
fair value as follows:
|
● |
Level 1 inputs are quoted prices available for identical assets and liabilities in active markets. |
|
|
|
|
● |
Level 2 inputs are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets or other inputs that are observable or can be corroborated by observable market data. |
|
|
|
|
● |
Level 3 inputs are less observable and reflect our own assumptions. |
The Company’s financial instruments consist
principally of cash and cash equivalents, accounts payable and accrued expenses, due to related parties, and notes payable. The carrying
amounts of such financial instruments in the accompanying condensed consolidated balance sheets approximate their fair values due to their
relatively short-term nature. It is management’s opinion that the Company is not exposed to any significant currency or credit risks
arising from these financial instruments.
Foreign Currency Translation and Transactions
The reporting
and functional currency of GEEC is the USD. The functional currency of GESPL, a wholly owned subsidiary of GEEC, is the Singapore Dollar
(“SGD”).
For financial
reporting purposes, the financial statements of the Company’s Singapore subsidiary, which are prepared using the SGD, are translated
into the Company’s reporting currency, USD. Assets and liabilities are translated using the exchange rate on the balance sheet date,
which was 0.7195 and 0.7368 as of June 30, 2022 and September 30, 2021, respectively. Revenue and expenses are translated using average
exchange rates prevailing during each reporting period. The 0.7341 and 0.7480 average exchange
rates were used to translate revenues and expenses for the nine months ended June 30, 2022 and 2021, respectively. Stockholders’
equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of
accumulated other comprehensive loss in stockholders’ equity.
Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transactions. The resulting exchange difference, presented as foreign currency transaction loss, is included in the
accompanying consolidated statements of operations.
Business Segments
The Company operates in only one segment.
Net Income (Loss) Per Share
The Company calculates net loss per share in accordance
with ASC Topic 260, “Earnings per Share.” Basic loss per share is computed by dividing the net loss by the weighted-average
number of common shares outstanding during the period. Diluted income per share is computed similar to basic loss per share except that
the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common
stock equivalents had been issued and if the additional common shares were dilutive. There were no potential dilutive debt or equity instruments
issued and outstanding at any time during the nine months ended June 30, 2022 and 2021.
Discounts on Common Stock
Common stock issued lower than the Company’s
par value is treated as common stock issued under discounts. The portion of the discount is shown separately as a deduction from the Company’s
account of common stock on the Company’s condensed consolidated financial statements.
Stock-Based Compensation
The Company
accounts for its stock-based compensation in which the Company obtains employee services in share-based payment transactions under FASB
ASC Topic 718, Compensation – Stock Compensation, which requires the Company to expense the cost of employee services received in
exchange for an award of equity instruments based on the grant date fair value of such instruments over the vesting period.
Income Taxes
Income taxes are accounted for under the asset
and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax
credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in
the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to
reduce the Company’s deferred tax assets to the amount that is more likely than not to be realized.
The Company considers positive and negative evidence
when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers,
among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration
of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate
realization of deferred tax assets is dependent upon its ability to generate sufficient future taxable income within the carry-forward
periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization
of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable
temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable
income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be reflected within the
industry.
The Company recognizes a tax benefit associated
with an uncertain tax position when, in its judgment, it is more likely than not that the position will be sustained upon examination
by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently
measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate
settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due
to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments
are recognized entirely in the period in which they are identified. The Company’s effective tax rate includes the net impact of
changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company
classifies interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense.
There were no current and deferred income tax
provision recorded for the nine months ended June 30, 2022 and 2021 since the Company is in developing stage and did not generate any
revenues in the two fiscal periods.
Recent Accounting Pronouncements
The Company
considers the applicability and impact of all Accounting Standards Updates (“ASUs” or “ASU”) on the Company’s
consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to
have minimal impact on the Company’s consolidated financial position or results of operations. Recently issued ASUs that the Company
feels may be applicable to the Company are as follows:
In August
2020, the FASB issued Accounting Standards Update No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). The subtitle is Accounting for Convertible Instruments
and Contracts in an Entity’s Own Equity. This ASU addresses complex financial instruments that have characteristics of both debt
and equity. The application of this ASU would reduce the number of accounting models for convertible debt instruments and convertible
preferred stock. Limiting the accounting models would result in fewer embedded conversion features being separately recognized from the
host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with
embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative,
and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial
premiums for which the premiums are recorded as paid-in capital. To date, no such bifurcation has been necessary. Management is evaluating
the potential impact. This ASU becomes effective for fiscal years beginning after December 15, 2023.
In March
2020, the FASB issued Accounting Standards Update No. 2020-03, Codification Improvements to Financial Instruments. There are seven issues
addressed in this update. Issues 1 through 5 were clarifications and codifications of previous updates. Issue 3 relates only to depository
and lending institutions and therefore would not be applicable to the Company. Issue 6 was a clarification on determining the contractual
term of a net investment in a lease for purposes of measuring expected credit losses, an issue not applicable to the Company. Issue 7
relates to the regaining control of financial assets sold and the recordation of an allowance for credit losses. The amendment related
to issues 1, 2, 4 and 5 become effective immediately upon adoption of the update. Issue 3 becomes effective for fiscal years beginning
after December 15, 2019. Issues 6 and 7 become effective on varying dates that relate to the dates of adoption other updates. Management’s
initial analysis is that it does not believe the new guidance will substantially impact the Company’s financial statements.
NOTE 3 – GOING CONCERN
As of June
30, 2022 and September 30, 2021, the Company had an accumulated deficit of $9,755,968 and $9,522,821, respectively. To date, the Company’s
cash flow requirements have been primarily met through proceeds received from sales of Common Stock. These and other factors raise substantial
doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments
to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company
not being able to continue as a going concern.
The Company
sold the 140,000 Hukui Shares for $350,000 cash on November 19, 2021. The proceeds will be used for operation expenses. Management believes
that these funds are sufficient to fund the Company’s expenses for at least the next 12 months.
NOTE 4 – INVESTMENT
Pursuant
to that certain Series C Preferred Shares Subscription Agreement dated September 23, 2020 between the Company and Hukui (the “Hukui
Agreement”), the Company agreed to purchase an aggregate 200,000 Series C Preferred Shares, at $10.00 per share, for an aggregate
investment of $2,000,000, in a series of three closings from December 15, 2020 through June 30, 2022. On December 15, 2020, the Company
purchased 80,000 shares of Series C Preferred Stock at $10.00 per share, for a total purchase price of $800,000; and on June 25, 2021,
the Company purchased an additional 60,000 shares of Series C Preferred Stock at $10.00 per share, for a total purchase price of $600,000.
The total $1,400,000 investment consists of less than 20% of Hukui’s total equity with no significant control over or influence
on Hukui. The investment is recorded at cost.
On November
17, 2021, the Company entered into a stock purchase agreement to sell all 140,000 Hukui Shares at $2.50 per share for a total of $350,000.
The sale was completed on November 19, 2021, resulting in loss of $1,050,000. The Company recognized impairment loss of the market value
of the shares of $1,050,000 for the year ended September 30, 2021.
NOTE 5 – STOCKHOLDERS’ EQUITY
The Company is authorized under its articles of
incorporation, as amended, to issue 10,000,000,000 shares of Common Stock, par value $0.001 per share.
Issuance of Common Stock
On December 15, 2020, the Company completed a
private offering of its Common Stock. The Company sold 107,000,000 shares of its Common Stock to 34 individuals at a purchase price of
$0.01 per share, for gross proceeds of $1,070,000, before allocating certain expenses associated with the offering in the amount of $5,852
as adjusted paid-in capital.
Effective March 31, 2021, the Company issued an
aggregate 6,399,965 shares of its Common Stock to certain of its directors, officers, employees and a consultant, who converted accrued
and unpaid compensation in the aggregate amount of $94,398. Of this amount, (i) $37,998 was with respect to amounts accrued during fiscal
year 2020 and was converted at a rate of $0.05 per share into an aggregate 759,965 shares of its Common Stock; and (ii) $56,400 was with
respect to amount accrued during the six months ended March 31, 2021 and was converted at a rate of $0.01 per share into an aggregate
5,640,000 shares of its Common Stock.
During the year ended September 30, 2021, one
of the Company’s shareholders made a loan to the Company in the principal amount of $30,000, primarily to pay our expenses. The
loan bore simple interest at a rate of 4% per annum and was payable as to both principal and interest on the maturity date of April 9,
2021. On the maturity date, the holder of the note converted the outstanding principal, together with accrued and unpaid interest of $598,
into 3,059,836 shares of the Company’s Common Stock, at the rate of $0.01 per share.
On June 15, 2021, the Company sold and issued
63,000,000 shares of Common Stock to 18 individuals, at purchase price of $0.01 per share, from a private offering of its Common Stock
(the “Spring 2021 Offering”). The gross proceeds were $630,000, before allocating certain expenses associated with the offering
in the amount of $7,230 as adjusted paid-in capital.
On July
15, 2021, the Company completed the Spring 2021 Offering of its Common Stock, on which date it sold and issued additional 10,000,000 shares
of its Common Stock to five individuals at a purchase price of $0.01 per share, for gross proceeds of $100,000, before allocating certain
expenses associated with the offering in the amount of $959 as adjusted paid-in capital.
Effective
September 30, 2021, the Company issued an aggregate 6,144,000 shares of its Common Stock to certain of its directors, officers, employees
and a consultant, who converted accrued and unpaid compensation in the aggregate amount of $61,440.
NOTE 6 – RELATED PARTY TRANSACTIONS
Related Parties
Name of related parties |
|
Relationship with the Company |
Yi Lung (Oliver) Lin |
|
Principal shareholder |
Jui Pin (John) Lin |
|
Principal shareholder, Director, Former President and Chief Executive Officer |
Jia Tian (Jeffery) Lin |
|
Former Chief Executive Officer |
Wen-Piao (Jack) Lai |
|
Director, Former Chief Executive Officer |
Shao-Cheng (Will) Wang |
|
Chief Financial Officer |
Kuang Ming (James) Tsai |
|
Director |
Nan-Yao (Jake) Chan |
|
Former Director |
Hsin-Ta (Darren) Su |
|
Director, Treasurer |
Due
to Related Parties
The Company’s
due to related parties balances are as follows:
| |
June 30, 2022 | | |
September 30, 2021 | |
Kuang Ming (James) Tsai | |
$ | 15,500 | | |
$ | 1,000 | |
Jui Pin (John) Lin | |
| 7,619 | | |
| 1,510 | |
Jia Tian (Jeffery) Lin | |
| 2,500 | | |
| - | |
Shao-Cheng (Will) Wang | |
| 20,700 | | |
| - | |
Wen-Piao (Jack) Lai | |
| 21,000 | | |
| - | |
Hsin-Ta (Darren) Su | |
| 19,679 | | |
| 500 | |
Total | |
$ | 86,998 | | |
$ | 3,010 | |
The related party balances are unsecured, interest-free
and due on demand.
NOTE 7 – INCOME TAXES
The Company has not generated any revenue from
any source in the United States and had consolidated net loss for all the years since inception in 2010. Management believes GEEC does
not have any U.S. income tax liability due. However, even though the Company does not have U.S. income tax liability, it may be required
to file Form 5471 each year with the Internal Revenue Service (the “IRS”) of Department of Treasury. GEEC falls in the Category
Five Filer (as a domestic corporation). The Company used to have subsidiaries: GEECIS in Sri Lanka that was established in May 2011, GESPL
in Singapore that was established in February 2012, and GESTL in Thailand that was established in December 2014. The subsidiaries in Sri
Lanka and Thailand were disposed in 2014 and 2016, respectively, and the Singapore subsidiary has been inactive since 2016.
During the
fiscal year ended September 30, 2021, the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return
of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30,
2020. The Company has engaged an outside professional advisor to seek for forgiveness of the penalty and interest thereon in the amount
of $3,476, for a total of $28,476, which was still pending as of June 30, 2022.
NOTE 8 – COMMITMENTS AND CONTINGENCIES
The Company terminated its previous virtual office
agreement in Los Angeles, California and has established a new virtual office in Arcadia, California. The new arrangement is on a month-to-month
basis at a cost of $200 per month. As of June 30, 2022, the Company had no material commitments under operating leases.
During the fiscal year ended September 30, 2021,
the IRS imposed a $25,000 penalty on the Company for failure to file Form 5472, Information Return
of a 25% Foreign-Owned U.S. Corporation or a Foreign Corporation Engaged in a U.S. Trade or Business, for the year ended September 30,
2020 (see Note 7).
NOTE 9 – SUBSEQUENT EVENTS
Management has evaluated subsequent events pursuant
to the requirements of ASC Topic 855, from the balance sheet date through the date when the condensed consolidated financial statements
were issued, and determined that no subsequent events occurred that would require adjustment to or disclosure in the condensed consolidated
financial statements